Works by Eriksson, Jan W.

Results: 103
    1

    Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1277, doi. 10.1111/dom.14698
    By:
    • Norhammar, Anna;
    • Bodegard, Johan;
    • Eriksson, Jan W.;
    • Haller, Hermann;
    • Linssen, Gerard C. M.;
    • Banerjee, Amitava;
    • Karasik, Avraham;
    • Mamouris, Pavlos;
    • Tangri, Navdeep;
    • Taveira‐Gomes, Tiago;
    • Maggioni, Aldo P.;
    • Botana, Manuel;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Yajima, Toshitaka;
    • Kadowaki, Takashi;
    • Birkeland, Kåre I.
    Publication type:
    Article
    2

    Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 75, doi. 10.1111/dom.14189
    By:
    • Birkeland, Kåre I.;
    • Bodegard, Johan;
    • Banerjee, Amitava;
    • Kim, Dae Jung;
    • Norhammar, Anna;
    • Eriksson, Jan W.;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Ha, Kyoung Hwa;
    • Kossack, Nils;
    • Mamza, Jil Billy;
    • Zhang, Ruiqi;
    • Yajima, Toshitaka;
    • Komuro, Issei;
    • Kadowaki, Takashi
    Publication type:
    Article
    3

    Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1607, doi. 10.1111/dom.14074
    By:
    • Birkeland, Kåre I.;
    • Bodegard, Johan;
    • Eriksson, Jan W.;
    • Norhammar, Anna;
    • Haller, Hermann;
    • Linssen, Gerard C.M.;
    • Banerjee, Amitava;
    • Thuresson, Marcus;
    • Okami, Suguru;
    • Garal‐Pantaler, Elena;
    • Overbeek, Jetty;
    • Mamza, Jil Billy;
    • Zhang, Ruiqi;
    • Yajima, Toshitaka;
    • Komuro, Issei;
    • Kadowaki, Takashi
    Publication type:
    Article
    4
    5
    6
    7
    8

    Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 344, doi. 10.1111/dom.13077
    By:
    • Persson, Frederik;
    • Nyström, Thomas;
    • Jørgensen, Marit E.;
    • Carstensen, Bendix;
    • Gulseth, Hanne L.;
    • Thuresson, Marcus;
    • Fenici, Peter;
    • Nathanson, David;
    • Eriksson, Jan W.;
    • Norhammar, Anna;
    • Bodegard, Johan;
    • Birkeland, Kåre I.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.

    Published in:
    2003
    By:
    • Kalani M;
    • Apelqvist J;
    • Blombäck M;
    • Brismar K;
    • Eliasson B;
    • Eriksson JW;
    • Fagrell B;
    • Hamsten A;
    • Torffvit O;
    • Jörneskog G;
    • Kalani, Majid;
    • Apelqvist, Jan;
    • Blombäck, Margareta;
    • Brismar, Kerstin;
    • Eliasson, Björn;
    • Eriksson, Jan W;
    • Fagrell, Bengt;
    • Hamsten, Anders;
    • Torffvit, Ole;
    • Jörneskog, Gun
    Publication type:
    journal article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50